NCT05499026View on ClinicalTrials.gov

Safety and Efficacy of CDCA in CTX Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX)

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

December 9, 2014

Primary Completion Date

June 3, 2015

Study Completion Date

June 3, 2015

Conditions
Cerebrotendinous Xanthomatoses
Interventions
DRUG

Chenodeoxycholic Acid

Bile acid

Sponsors
All Listed Sponsors
lead

Leadiant Biosciences Ltd.

INDUSTRY

NCT05499026 - Safety and Efficacy of CDCA in CTX Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX) | Biotech Hunter | Biotech Hunter